Enterprise Value
97.81M
Cash
33.94M
Avg Qtr Burn
-10.06M
Short % of Float
16.06%
Insider Ownership
65.13%
Institutional Own.
5.81%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NE3107 Details Alzheimer's disease | Phase 3 Update | |
NE3107 Details Parkinson's disease | Phase 3 Initiation | |
BIV201 Details Ascites | Phase 2b Update |